X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs GSK PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD GSK PHARMA ALEMBIC LTD/
GSK PHARMA
 
P/E (TTM) x 55.4 66.9 82.8% View Chart
P/BV x 3.1 11.7 26.6% View Chart
Dividend Yield % 0.4 1.1 33.3%  

Financials

 ALEMBIC LTD   GSK PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
GSK PHARMA
Mar-17
ALEMBIC LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs533,838 1.4%   
Low Rs292,637 1.1%   
Sales per share (Unadj.) Rs4.7354.2 1.3%  
Earnings per share (Unadj.) Rs8.839.8 22.1%  
Cash flow per share (Unadj.) Rs9.042.9 21.0%  
Dividends per share (Unadj.) Rs0.1530.00 0.5%  
Dividend yield (eoy) %0.40.9 39.4%  
Book value per share (Unadj.) Rs27.7236.9 11.7%  
Shares outstanding (eoy) m267.0384.70 315.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x8.79.1 95.2%   
Avg P/E ratio x4.781.4 5.7%  
P/CF ratio (eoy) x4.675.5 6.0%  
Price / Book Value ratio x1.513.7 10.8%  
Dividend payout %1.775.4 2.3%   
Avg Mkt Cap Rs m10,962274,216 4.0%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m2384,830 4.9%   
Avg. sales/employee Rs ThNM6,387.0-  
Avg. wages/employee Rs ThNM1,028.3-  
Avg. net profit/employee Rs ThNM717.1-  
INCOME DATA
Net Sales Rs m1,26030,000 4.2%  
Other income Rs m264728 36.2%   
Total revenues Rs m1,52430,728 5.0%   
Gross profit Rs m834,190 2.0%  
Depreciation Rs m61263 23.3%   
Interest Rs m00-   
Profit before tax Rs m2854,655 6.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-32457 -7.0%   
Tax Rs m61,744 0.3%   
Profit after tax Rs m2,3433,368 69.6%  
Gross profit margin %6.614.0 47.0%  
Effective tax rate %2.137.5 5.7%   
Net profit margin %185.911.2 1,655.8%  
BALANCE SHEET DATA
Current assets Rs m1,68916,742 10.1%   
Current liabilities Rs m4867,202 6.8%   
Net working cap to sales %95.431.8 300.1%  
Current ratio x3.52.3 149.4%  
Inventory Days Days21752 418.7%  
Debtors Days Days8121 389.9%  
Net fixed assets Rs m1,6248,635 18.8%   
Share capital Rs m534847 63.1%   
"Free" reserves Rs m5,96019,222 31.0%   
Net worth Rs m7,40420,069 36.9%   
Long term debt Rs m10410 1,043.0%   
Total assets Rs m8,01030,038 26.7%  
Interest coverage x950.7NM-  
Debt to equity ratio x00 2,827.1%  
Sales to assets ratio x0.21.0 15.8%   
Return on assets %29.311.2 260.9%  
Return on equity %31.616.8 188.5%  
Return on capital %31.325.5 122.9%  
Exports to sales %2.90-   
Imports to sales %28.90-   
Exports (fob) Rs m37NA-   
Imports (cif) Rs m364NA-   
Fx inflow Rs m37528 7.0%   
Fx outflow Rs m3657,193 5.1%   
Net fx Rs m-328-6,665 4.9%   
CASH FLOW
From Operations Rs m3462,360 14.6%  
From Investments Rs m-483,008 -1.6%  
From Financial Activity Rs m-301-5,108 5.9%  
Net Cashflow Rs m-3260 -1.2%  

Share Holding

Indian Promoters % 64.0 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 0.2 10.2 2.0%  
FIIs % 9.7 23.8 40.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 15.4 169.5%  
Shareholders   54,701 102,036 53.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day in Red; Pharma Stocks Lose Most(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a negative note.

Related Views on News

GSK PHARMA Announces Quarterly Results (4QFY18); Net Profit Down 6.4%

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 6.4% YoY). Sales on the other hand came in at Rs 7 bn (down 4.5% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Jun 21, 2018 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD - DIVIS LABORATORIES COMPARISON

COMPARE ALEMBIC LTD WITH

MARKET STATS